Related Experiment Video
Updated: Jul 24, 2026
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases.
O H Sanchez-Sweatman1, F W Orr, G Singh
1Hamilton Regional Cancer Centre, McMaster University, Hamilton, Canada.
Invasion & Metastasis
|March 24, 2000
Summary
Prostate cancer cells can directly break down bone tissue, contributing to fractures. Matrix metalloproteinases play a key role in this bone degradation process.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Bone metastases are common in advanced cancers, leading to osteolysis and pathological fractures.
- Metastatic cancer cells' ability to degrade bone matrix is crucial for skeletal invasion and destruction.
Purpose of the Study:
- To investigate if human prostate cancer cells (PC3) can directly degrade non-mineralized and mineralized bone.
- To elucidate the role of matrix metalloproteinases (MMPs) in this bone degradation process.
Main Methods:
- Utilized prostate adenocarcinoma cell line PC3, established from skeletal metastases.
- Assessed degradation of non-mineralized extracellular matrices and mineralized bone slices.
- Measured calcium-45 release and resorption pit formation on bone.
- Investigated the effect of transforming growth factor-beta(1) and MMPs.
Main Results:
- PC3 cells and their conditioned medium degraded non-mineralized osteoid-like matrices.
- PC3 cells induced calcium release and formed resorption pits on mineralized bone.
- Matrix degradation was enhanced by transforming growth factor-beta(1).
- Matrix metalloproteinases were implicated through TPA stimulation, inhibition by 1,10-phenanthroline, and type I collagen degradation.
Conclusions:
- Human prostate cancer cells possess the capability to directly degrade bone-related matrices.
- Matrix metalloproteinases are significantly involved in the bone degradation mediated by prostate cancer cells.
